Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte: Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares

Translated title of the contribution: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions

Michael Bauer, Peter C. Whybrow, Jules Angst, Marcio Versiani, Hans Jürgen Möller, Hervé Allain, Ian Anderson, José L. Ayuso-Gutierrez, David Baldwin, Per Bech, Otto Benkert, Michael Berk, Istvan Bitter, Marc L. Bourgeois, Graham Burrows, Giovanni Cassano, Marcelo Cetkovich-Bakmans, John C. Cookson, Delcir Da Costa, Mihai D. GherogheGerardo Heinze, Teruhiko Higuchi, Robert M. Hirschfeld, Cyril Höschl, Edith Holsboer-Trachsler, Siegfried Kasper, Cornelius Katona, Martin B. Keller, Parmanand Kulhara, David J. Kupfer, Yves Lecrubier, Brian Leonard, Rasmus W. Licht, Odd Lingjaerde, Henrik Lublin, Julien Mendlewicz, Philip Mitchell, Eugene S. Paykel, Stanislaw Puzynski, A. John Rush, Janusz K. Rybakowski, Isaac Schweitzer, Jürgen Unützer, Per Verstergaard, Eduard Vieta, Kazuo Yamada, Jens Wiltfang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of the complete spectrum of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). The first part of these WFSBP guidelines on unipolar depressive disorders covered the acute and continuation treatment of major depressive disorder (Bauer et al., 2002). This second part of the guidelines covers the management of the maintenance-phase treatment of major depressive disorder, as well as the treatment of chronic and subthreshold depressive disorders (dysthymic disorder, double depression, minor depressive disorder and recurrent brief depression). These guidelines are primarily concerned with thebiological treatment (including antidepressants, lithium, other psychopharmacological and hormonal medications, and electroconvulsive therapy) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.

Original languageUndefined
Pages (from-to)58-76
Number of pages19
JournalRevista de Psiquiatria Clinica
Volume36
Issue numberSUPPL. 2
DOIs
StatePublished - 2009

Fingerprint

Biological Psychiatry
Major Depressive Disorder
Depressive Disorder
Guidelines
Depression
Therapeutics
Antidepressive Agents
Dysthymic Disorder
Electroconvulsive Therapy
Advisory Committees
Lithium
Practice Guidelines
MEDLINE
Libraries
Meta-Analysis
Young Adult
Maintenance
Databases
Physicians

Keywords

  • Antidepressants
  • Chronic depressive disorders
  • Depressive disorders
  • Dysthymic disorder
  • ECT
  • Evidence-based guidelines
  • Lithium
  • Maintenance treatment
  • Major depressive disorder
  • Pharmacotherapy
  • Subthreshold

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte : Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares. / Bauer, Michael; Whybrow, Peter C.; Angst, Jules; Versiani, Marcio; Möller, Hans Jürgen; Allain, Hervé; Anderson, Ian; Ayuso-Gutierrez, José L.; Baldwin, David; Bech, Per; Benkert, Otto; Berk, Michael; Bitter, Istvan; Bourgeois, Marc L.; Burrows, Graham; Cassano, Giovanni; Cetkovich-Bakmans, Marcelo; Cookson, John C.; Costa, Delcir Da; Gheroghe, Mihai D.; Heinze, Gerardo; Higuchi, Teruhiko; Hirschfeld, Robert M.; Höschl, Cyril; Holsboer-Trachsler, Edith; Kasper, Siegfried; Katona, Cornelius; Keller, Martin B.; Kulhara, Parmanand; Kupfer, David J.; Lecrubier, Yves; Leonard, Brian; Licht, Rasmus W.; Lingjaerde, Odd; Lublin, Henrik; Mendlewicz, Julien; Mitchell, Philip; Paykel, Eugene S.; Puzynski, Stanislaw; Rush, A. John; Rybakowski, Janusz K.; Schweitzer, Isaac; Unützer, Jürgen; Verstergaard, Per; Vieta, Eduard; Yamada, Kazuo; Wiltfang, Jens.

In: Revista de Psiquiatria Clinica, Vol. 36, No. SUPPL. 2, 2009, p. 58-76.

Research output: Contribution to journalArticle

Bauer, M, Whybrow, PC, Angst, J, Versiani, M, Möller, HJ, Allain, H, Anderson, I, Ayuso-Gutierrez, JL, Baldwin, D, Bech, P, Benkert, O, Berk, M, Bitter, I, Bourgeois, ML, Burrows, G, Cassano, G, Cetkovich-Bakmans, M, Cookson, JC, Costa, DD, Gheroghe, MD, Heinze, G, Higuchi, T, Hirschfeld, RM, Höschl, C, Holsboer-Trachsler, E, Kasper, S, Katona, C, Keller, MB, Kulhara, P, Kupfer, DJ, Lecrubier, Y, Leonard, B, Licht, RW, Lingjaerde, O, Lublin, H, Mendlewicz, J, Mitchell, P, Paykel, ES, Puzynski, S, Rush, AJ, Rybakowski, JK, Schweitzer, I, Unützer, J, Verstergaard, P, Vieta, E, Yamada, K & Wiltfang, J 2009, 'Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte: Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares', Revista de Psiquiatria Clinica, vol. 36, no. SUPPL. 2, pp. 58-76. https://doi.org/10.1590/S0101-60832009000800002
Bauer, Michael ; Whybrow, Peter C. ; Angst, Jules ; Versiani, Marcio ; Möller, Hans Jürgen ; Allain, Hervé ; Anderson, Ian ; Ayuso-Gutierrez, José L. ; Baldwin, David ; Bech, Per ; Benkert, Otto ; Berk, Michael ; Bitter, Istvan ; Bourgeois, Marc L. ; Burrows, Graham ; Cassano, Giovanni ; Cetkovich-Bakmans, Marcelo ; Cookson, John C. ; Costa, Delcir Da ; Gheroghe, Mihai D. ; Heinze, Gerardo ; Higuchi, Teruhiko ; Hirschfeld, Robert M. ; Höschl, Cyril ; Holsboer-Trachsler, Edith ; Kasper, Siegfried ; Katona, Cornelius ; Keller, Martin B. ; Kulhara, Parmanand ; Kupfer, David J. ; Lecrubier, Yves ; Leonard, Brian ; Licht, Rasmus W. ; Lingjaerde, Odd ; Lublin, Henrik ; Mendlewicz, Julien ; Mitchell, Philip ; Paykel, Eugene S. ; Puzynski, Stanislaw ; Rush, A. John ; Rybakowski, Janusz K. ; Schweitzer, Isaac ; Unützer, Jürgen ; Verstergaard, Per ; Vieta, Eduard ; Yamada, Kazuo ; Wiltfang, Jens. / Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte : Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares. In: Revista de Psiquiatria Clinica. 2009 ; Vol. 36, No. SUPPL. 2. pp. 58-76.
@article{7e590fc969be49f9b8bcdc8a4b14fa45,
title = "Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biol{\'o}gico de transtornos depressivos unipolares, 2a parte: Tratamento de manuten{\cc}{\~a}o do transtorno depressivo maior e tratamento dos transtornos depressivos cr{\^o}nicos e das depress{\~o}es subliminares",
abstract = "These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of the complete spectrum of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). The first part of these WFSBP guidelines on unipolar depressive disorders covered the acute and continuation treatment of major depressive disorder (Bauer et al., 2002). This second part of the guidelines covers the management of the maintenance-phase treatment of major depressive disorder, as well as the treatment of chronic and subthreshold depressive disorders (dysthymic disorder, double depression, minor depressive disorder and recurrent brief depression). These guidelines are primarily concerned with thebiological treatment (including antidepressants, lithium, other psychopharmacological and hormonal medications, and electroconvulsive therapy) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.",
keywords = "Antidepressants, Chronic depressive disorders, Depressive disorders, Dysthymic disorder, ECT, Evidence-based guidelines, Lithium, Maintenance treatment, Major depressive disorder, Pharmacotherapy, Subthreshold",
author = "Michael Bauer and Whybrow, {Peter C.} and Jules Angst and Marcio Versiani and M{\"o}ller, {Hans J{\"u}rgen} and Herv{\'e} Allain and Ian Anderson and Ayuso-Gutierrez, {Jos{\'e} L.} and David Baldwin and Per Bech and Otto Benkert and Michael Berk and Istvan Bitter and Bourgeois, {Marc L.} and Graham Burrows and Giovanni Cassano and Marcelo Cetkovich-Bakmans and Cookson, {John C.} and Costa, {Delcir Da} and Gheroghe, {Mihai D.} and Gerardo Heinze and Teruhiko Higuchi and Hirschfeld, {Robert M.} and Cyril H{\"o}schl and Edith Holsboer-Trachsler and Siegfried Kasper and Cornelius Katona and Keller, {Martin B.} and Parmanand Kulhara and Kupfer, {David J.} and Yves Lecrubier and Brian Leonard and Licht, {Rasmus W.} and Odd Lingjaerde and Henrik Lublin and Julien Mendlewicz and Philip Mitchell and Paykel, {Eugene S.} and Stanislaw Puzynski and Rush, {A. John} and Rybakowski, {Janusz K.} and Isaac Schweitzer and J{\"u}rgen Un{\"u}tzer and Per Verstergaard and Eduard Vieta and Kazuo Yamada and Jens Wiltfang",
year = "2009",
doi = "10.1590/S0101-60832009000800002",
language = "Undefined",
volume = "36",
pages = "58--76",
journal = "Revista de Psiquiatria Clinica",
issn = "0101-6083",
publisher = "Lemos Editorial e Graficos Ltda",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte

T2 - Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares

AU - Bauer, Michael

AU - Whybrow, Peter C.

AU - Angst, Jules

AU - Versiani, Marcio

AU - Möller, Hans Jürgen

AU - Allain, Hervé

AU - Anderson, Ian

AU - Ayuso-Gutierrez, José L.

AU - Baldwin, David

AU - Bech, Per

AU - Benkert, Otto

AU - Berk, Michael

AU - Bitter, Istvan

AU - Bourgeois, Marc L.

AU - Burrows, Graham

AU - Cassano, Giovanni

AU - Cetkovich-Bakmans, Marcelo

AU - Cookson, John C.

AU - Costa, Delcir Da

AU - Gheroghe, Mihai D.

AU - Heinze, Gerardo

AU - Higuchi, Teruhiko

AU - Hirschfeld, Robert M.

AU - Höschl, Cyril

AU - Holsboer-Trachsler, Edith

AU - Kasper, Siegfried

AU - Katona, Cornelius

AU - Keller, Martin B.

AU - Kulhara, Parmanand

AU - Kupfer, David J.

AU - Lecrubier, Yves

AU - Leonard, Brian

AU - Licht, Rasmus W.

AU - Lingjaerde, Odd

AU - Lublin, Henrik

AU - Mendlewicz, Julien

AU - Mitchell, Philip

AU - Paykel, Eugene S.

AU - Puzynski, Stanislaw

AU - Rush, A. John

AU - Rybakowski, Janusz K.

AU - Schweitzer, Isaac

AU - Unützer, Jürgen

AU - Verstergaard, Per

AU - Vieta, Eduard

AU - Yamada, Kazuo

AU - Wiltfang, Jens

PY - 2009

Y1 - 2009

N2 - These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of the complete spectrum of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). The first part of these WFSBP guidelines on unipolar depressive disorders covered the acute and continuation treatment of major depressive disorder (Bauer et al., 2002). This second part of the guidelines covers the management of the maintenance-phase treatment of major depressive disorder, as well as the treatment of chronic and subthreshold depressive disorders (dysthymic disorder, double depression, minor depressive disorder and recurrent brief depression). These guidelines are primarily concerned with thebiological treatment (including antidepressants, lithium, other psychopharmacological and hormonal medications, and electroconvulsive therapy) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.

AB - These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of the complete spectrum of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). The first part of these WFSBP guidelines on unipolar depressive disorders covered the acute and continuation treatment of major depressive disorder (Bauer et al., 2002). This second part of the guidelines covers the management of the maintenance-phase treatment of major depressive disorder, as well as the treatment of chronic and subthreshold depressive disorders (dysthymic disorder, double depression, minor depressive disorder and recurrent brief depression). These guidelines are primarily concerned with thebiological treatment (including antidepressants, lithium, other psychopharmacological and hormonal medications, and electroconvulsive therapy) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.

KW - Antidepressants

KW - Chronic depressive disorders

KW - Depressive disorders

KW - Dysthymic disorder

KW - ECT

KW - Evidence-based guidelines

KW - Lithium

KW - Maintenance treatment

KW - Major depressive disorder

KW - Pharmacotherapy

KW - Subthreshold

UR - http://www.scopus.com/inward/record.url?scp=77949747786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949747786&partnerID=8YFLogxK

U2 - 10.1590/S0101-60832009000800002

DO - 10.1590/S0101-60832009000800002

M3 - Article

AN - SCOPUS:77949747786

VL - 36

SP - 58

EP - 76

JO - Revista de Psiquiatria Clinica

JF - Revista de Psiquiatria Clinica

SN - 0101-6083

IS - SUPPL. 2

ER -